Avadel Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Avadel Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Avadel Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avadel Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.6M | 566k | 15.27 |
| 2025-03-31 | $908k | 116k | 7.83 |
| 2024-12-31 | $1.2M | 111k | 10.51 |
| 2024-09-30 | $1.5M | 115k | 13.11 |
| 2024-06-30 | $1.6M | 113k | 14.06 |